BiomEdit CEO Aaron Schacht joins the Cures & Capital podcast to discuss improving R&D productivity across the pharmaceutical industry, drawing on his Eli Lilly leadership experience and a landmark Nature Reviews Drug Discovery framework. Also available as audio on Spotify and Apple Podcasts.
Cures & Capital (YouTube/Podcast) · April 22, 2025
Aaron Schacht on the Pharmaceutical Industry's Grand Challenge and Managing R&D at Scale
CEO Aaron Schacht discusses improving biopharma R&D productivity, drawing on his Eli Lilly leadership experience and a landmark Nature Reviews Drug Discovery framework.
